Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Young Man with Cognitive Impairment and a Heart Condition. | J Alzheimers Dis | 2022 | 35871352 | PubTator, text mining | PubMed |
| Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling. | Stem Cell Res Ther | 2022 | 35870954 | PubTator, text mining | PubMed |
| The Effect of Growth Hormone Therapy on Cardiac Outcomes in Noonan Syndrome: Long Term Follow-up Results | J Clin Res Pediatr Endocrinol | 2022 | 35859537 | PubTator, text mining | PubMed |
| Role of Posttranslational Modifications of Proteins in Cardiovascular Disease. | Oxid Med Cell Longev | 2022 | 35855865 | PubTator, text mining | PubMed |
| Protein Quality Control at the Sarcomere: Titin Protection and Turnover and Implications for Disease Development. | Front Physiol | 2022 | 35846001 | PubTator, text mining | PubMed |
| Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking. | Evid Based Complement Alternat Med | 2022 | 35845584 | PubTator, text mining | PubMed |
| What Causes Hypertrophic Cardiomyopathy? | Am J Cardiol | 2022 | 35843734 | PubTator, text mining | PubMed |
| Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis. | ESC Heart Fail | 2022 | 35842920 | PubTator, text mining | PubMed |
| Human adaptation to high altitude: a review of convergence between genomic and proteomic signatures. | Hum Genomics | 2022 | 35841113 | PubTator, text mining | PubMed |
| Heterogeneous Distribution of Genetic Mutations in Myosin Binding Protein-C Paralogs. | Front Genet | 2022 | 35832193 | PubTator, text mining | PubMed |
| Sarcomeric gene mutations in phenotypic positive hypertrophic cardiomyopathic patients in Indian population. | Cell Mol Biol (Noisy-le-grand) | 2022 | 35818221 | PubTator, text mining | PubMed |
| Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis. | Cells | 2022 | 35805205 | PubTator, text mining | PubMed |
| Frequency of actionable Exomic secondary findings in 160 Colombian patients: Impact in the healthcare system. | Gene | 2022 | 35803546 | PubTator, text mining | PubMed |
| Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene. | Front Genet | 2022 | 35795207 | PubTator, text mining | PubMed |
| Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy. | Diabetes Care | 2022 | 35789379 | PubTator, text mining | PubMed |
| Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy. | Front Cell Dev Biol | 2022 | 35784482 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy in the Elderly: A Case Identified With Genetic Screening. | J Investig Med High Impact Case Rep | 2022 | 35778879 | PubTator, text mining | PubMed |
| Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to 'burn out'. | Eur Heart J Case Rep | 2022 | 35775015 | PubTator, text mining | PubMed |
| An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene. | Stem Cell Res | 2022 | 35772297 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function. | Elife | 2022 | 35767336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=43